Medtronic gets FDA approval for spinal cord stimulation platform

Medtronic received FDA approval for its spinal cord stimulator, Vanta.

Advertisement

Vanta is a rechargeable-free stimulator and can be optimized for up to 11 years, according to a June 10 news release. It uses Medtronic’s proprietary AdaptiveStim technology for custom pain relief.

Vanta also works with Medtronic’s CareGuidePro app. It allows patients and physicians to monitor spinal cord stimulation outcomes and was launched in May.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Outpatient Spine

  • Spine surgery is moving outpatient quickly, but the hospital is not disappearing from the equation. Lumbar fusions, cervical disc replacements…

  • Advances in endoscopic surgery, robotics, motion preservation and complex reconstruction are expanding what is possible in spine care. Surgeons across…

Advertisement

Comments are closed.